The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Therapeutic Pipeline Program, 2018Development of ALK4290 as a Novel Parkinson's Therapeutic
Study Rationale:
There is clear evidence that the immune system plays an important role in the development and progression of Parkinson's disease. Novel therapies targeting the recruitment of immune... -
Target Advancement Program, 2018Searching for Cellular Changes Associated with PINK1 and PRKN Mutations
Study Rationale:
PINK1 and parkin are two proteins that work together to keep cells healthy by ridding them of damaged mitochondria, cells' powerhouses. Mutations (changes) in the PINK1 and PRKN genes... -
Target Advancement Program, 2018Validating Astrocyte-produced Protein GDF15 as a Novel Neuroprotective Therapy
Study Rationale:
In Parkinson's disease (PD), death of dopamine-producing brain cells takes place mainly the substantia nigra pars compacta (SN) but not in the neighboring ventral tegmental area (VTA)... -
Target Advancement Program, 2018Testing the Ability of Clenbuterol to Prevent or Modify the Course of Parkinson's Disease
Study Rationale:
Protein alpha-synuclein clumps in the brains of people with Parkinson's disease (PD), forming Lewy bodies. Recent studies have suggested that beta-2 adrenoreceptor agonists -- drugs... -
Mitochondrial Biomarkers Program, 2018Changes in Mitochondrial DNA as Diagnostic and Progression Biomarkers of Parkinson's Disease
Study Rationale:
Biomarkers, or objective measures, of Parkinson's disease (PD) could help identify individuals at risk of PD and predict disease progression. According to recent studies, changes in... -
Inflammation Biomarkers Program, 2018The Kynurenine Pathway as a New Therapeutic Target and Source of Biomarkers for Parkinson's Disease
Study Rationale:
Inflammation is involved in the death of brain cells in Parkinson's disease (PD), but the exact relationship between the two is unclear. We propose that inflammation damages the brain...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.